Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Stock Information for Conduit Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Announces Leadership Changes
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
Conduit Progresses Phase II of its AI Initiative with Sarborg

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.